GlassScriptPhysician profile
Hubert M Chodkiewicz
NPI 1265797427
$12,664.78
in general payments reported to CMS, 2019-2025
32 companies · $2,047 in 2025
The $2,047 reported for 2025 was more than what 88% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,708 · 2020: $874 · 2021: $1,163 · 2022: $1,716 · 2023: $2,682 · 2024: $2,475 · 2025: $2,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,109 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,108.81 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,497.15 | 2020-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $2,077.86 | 2019-2025 | Botox, Skyrizi, Rinvoq |
| Galderma Laboratories, L.P. | $816.56 | 2019-2025 | Nemluvio, Aklief, Epsolay |
| Sun Pharmaceutical Industries INC. | $680.56 | 2019-2025 | Absorica Ld, Winlevi |
| Genzyme Corporation | $663.90 | 2019-2025 | |
| Lilly USA, LLC | $611.70 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Almirall LLC | $521.42 | 2019-2025 | Seysara |
| Amgen INC. | $513.54 | 2020-2025 | Otezla, Otezla |
| Merz North America, INC. | $467.51 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $420.05 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $420.03 | 2019-2025 | Libtayo, Dupixent |
| Leo Pharma INC. | $402.04 | 2019-2025 | Adbry |
| Mayne Pharma Commercial LLC | $318.21 | 2019-2025 | |
| Allergan, INC. | $258.29 | 2019-2022 | |
| Ucb, INC. | $256.58 | 2019-2025 | Bimzelx |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $250.15 | 2019-2025 | Cabtreo, Arazlo, Siliq |
| Pfizer INC. | $218.02 | 2019-2024 | |
| Incyte Corporation | $214.79 | 2022-2024 | Opzelura |
| Vyne Pharmaceuticals INC. | $202.68 | 2020-2021 | |
| Biofrontera INC. | $179.15 | 2019-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Revance Therapeutics, INC. | $150.78 | 2025 | Daxxify |
| Journey Medical Corporation | $84.39 | 2022-2023 | |
| Arcutis Biotherapeutics, INC. | $81.47 | 2023-2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $77.27 | 2022-2023 | Sotyktu |
| Botanix Sb INC | $70.26 | 2025 | Sofdra |
| Dermavant Sciences, INC. | $54.08 | 2023-2024 | Vtama |
| Solta Medical, A Division of Bausch Health US, LLC | $39.42 | 2019-2025 | Clear & Brilliant, Fraxel |
| Dermira, INC. | $36.76 | 2020-2021 | |
| Organon LLC | $28.53 | 2025 | |
| Celgene Corporation | $20.67 | 2019 | |
| Medimetriks Pharmaceuticals, INC. | $16.94 | 2022 | |
| Aclaris Therapeutics, INC. | $14.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hubert Chodkiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.